Andra AP fonden Sells 42,620 Shares of CME Group Inc. $CME

Andra AP fonden lessened its stake in CME Group Inc. (NASDAQ:CME) by 29.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 102,680 shares of the financial services provider’s stock after selling 42,620 shares during the period. Andra AP fonden’s holdings in CME Group were worth $28,040,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Asset Dedication LLC increased its holdings in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $27,000. Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $28,000. Legacy Wealth Managment LLC ID increased its position in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares during the last quarter. Finally, Global Wealth Strategies & Associates increased its position in shares of CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group launched Nasdaq CME Crypto Index futures, giving investors regulated exposure to a basket of major digital assets such as Bitcoin, Ethereum, Solana, XRP, Cardano, Chainlink, and Stellar. This could attract fresh institutional trading and hedging activity. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
• Positive Sentiment: The company announced four new E-mini futures contracts tied to broad U.S. equity benchmarks, expanding its equity index franchise and potentially increasing trading volumes. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
• Positive Sentiment: CME also unveiled financially settled Micro E-mini S&P 500 and Nasdaq-100 options, which should broaden access for smaller traders and add another potential source of contract activity. CME Group to Launch New Financially-Settled Micro E-mini S&P 500 and Nasdaq-100 Options
• Positive Sentiment: CME said it will expand 24/7 trading for smaller WTI crude oil and gold contracts, a move that could improve market access and price discovery while boosting engagement in its commodities products. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
• Positive Sentiment: CME entered an exclusive multi-year licensing deal with Morningstar to launch derivatives based on key Morningstar equity indexes, opening a new product line tied to more than $3 trillion in linked assets. CME Group and Morningstar Announce Exclusive Index Derivatives Licensing Agreement
• Neutral Sentiment: Analysts at Erste Group Bank slightly raised FY2026 earnings estimates for CME, but kept a Hold rating. That signals modestly improved expectations, though not a strong new bullish call.
• Neutral Sentiment: Shareholders maintained CME’s Class B governance structure, which removes uncertainty around a possible change but is unlikely to be a major near-term operating catalyst. CME Group Shareholders Maintain Class B Governance Structure
• Neutral Sentiment: Cardano futures on CME are nearing the six-month threshold that could help an ETF application qualify, but the potential benefit is indirect and still months away. SEC Clock Ticks as Cardano Futures Edge Toward ETF Qualification

CME Group Stock Down 0.6%

Shares of NASDAQ:CME opened at $262.18 on Friday. The stock’s 50-day moving average price is $285.34 and its 200-day moving average price is $288.20. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16. The stock has a market capitalization of $95.00 billion, a P/E ratio of 22.37, a price-to-earnings-growth ratio of 2.95 and a beta of 0.21. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the firm earned $2.80 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. On average, equities analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Wall Street Analysts Forecast Growth

CME has been the subject of several research reports. Piper Sandler increased their price objective on CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. JPMorgan Chase & Co. increased their price objective on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. Deutsche Bank Aktiengesellschaft lowered their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Argus reiterated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Finally, Raymond James Financial raised their price target on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $305.71.

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 44,044 shares of company stock valued at $13,297,507 over the last ninety days. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.